Form 4 for OPRX OptimizeRx Corp
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-05 · accession 0001213900-21-051449 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-05 | 2021-10-05 | OPRX | BAKER DOUGLAS P | CFO | M - OptEx | $7.51 | +10.0K | 44.8K | +29% | +$75.1K |
| DM | 2021-10-05 | 2021-10-05 | OPRX | BAKER DOUGLAS P | CFO | S - Sale+OE | $82.88 | -14.0K | 34.8K | -29% | -$1.16M |
| D | 2021-10-05 | 2021-10-05 | OPRX | BAKER DOUGLAS P | CFO | M - OptEx | $7.51 | -10.0K | 34.7K | -22% | -$75.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-05 | M | A | 10,000 | $7.51 | 44,796 | D | — | — | |
| 2 | Common | Common Stock (pursuant to 10B5-1 plan) | 2021-10-05 | S | D | 4,000 | $84.22 | 34,796 | D | — | — | (F2) These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| 3 | Common | Common Stock (pursuant to 10B5-1 plan) | 2021-10-05 | S | D | 10,000 | $82.35 | 34,796 | D | — | — | (F1) These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| 4 | Derivative | Stock Option | 2021-10-05 | M | D | 10,000 | $7.51 | 34,699 | D | $7.51 · 2020-06-30 to 2025-03-11 | 10,000 Common Stock |